EV/EBITDA
13.53
+2.77+25.74%
Mon, 23 Dec 2024 14:30:00 GMT
Summary:
XTL Biopharmaceuticals EV/EBITDA is currently 13.53, with a rise of +2.77 (+25.74%) during the most recent trading day. Over the past year, it has increased by +18.11 (+395.41%). XTLB EV/EBITDA is now -95.24% below its all-time high of 284.18.XTLB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +25.7% |
| 1 m1 month | -7.1% |
| 3 m3 months | -30.3% |
| 6 m6 months | -22.7% |
| ytdytd | +411.0% |
| 1 y1 year | +395.4% |
| 5 y5 years | +720.6% |
XTLB EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 15.34 | -11.8% | 10.76 | +25.7% |
| 3 m | 3 months | 20.71 | -34.7% | 8.34 | +62.2% |
| 6 m | 6 months | 24.43 | -44.6% | 8.34 | +62.2% |
| 1 y | 1 year | 26.07 | -48.1% | -5.29 | +355.8% |
| 3 y | 3 years | 121.44 | -88.9% | -12.71 | +206.4% |
| 5 y | 5 years | 121.44 | -88.9% | -20.07 | +167.4% |
| alltime | all time | 284.18 | -95.2% | -206.77 | +106.5% |
XTL Biopharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 13.53(-411.0%) |
| 2023 | -4.35(-14.9%) |
| 2022 | -5.11(-34.4%) |
| 2021 | -7.79(-33.1%) |
| 2020 | -11.64(+277.9%) |
| 2019 | -3.08(-56.7%) |
| 2018 | -7.11(+4.4%) |
| 2017 | -6.81(+75.5%) |
| 2016 | -3.88(-49.4%) |
| 2015 | -7.67(-39.6%) |
| Date | Value |
|---|---|
| 2014 | -12.70(-54.9%) |
| 2013 | -28.13(-20.0%) |
| 2012 | -35.16(+8.2%) |
| 2011 | -32.49(-8.8%) |
| 2010 | -35.64(-7683.0%) |
| 2009 | 0.47(+261.5%) |
| 2008 | 0.13(-105.4%) |
| 2007 | -2.39(+10.1%) |
| 2006 | -2.17(-70.5%) |
| 2005 | -7.36 |
FAQ
- What is XTL Biopharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for XTL Biopharmaceuticals?
- What is XTLB EV/EBITDA year-to-date change?
- What is XTL Biopharmaceuticals EV/EBITDA year-on-year change?
What is XTL Biopharmaceuticals EV/EBITDA?
The current EV/EBITDA of XTLB is 13.53
What is the all time high EV/EBITDA for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high EV/EBITDA is 284.18
What is XTLB EV/EBITDA year-to-date change?
XTL Biopharmaceuticals EV/EBITDA has changed by +17.88 (+411.03%) since the beginning of the year
What is XTL Biopharmaceuticals EV/EBITDA year-on-year change?
Over the past year, XTLB EV/EBITDA has changed by +18.11 (+395.41%)